E. M. Gomes

Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (São Gonçalo do Amarante, RN).

E. Paraguai de Souza, K. Luz, V. D. da Silva, 2002, Vaccine.

Leishmania donovani: titration of antibodies to the fucose-mannose ligand as an aid in diagnosis and prognosis of visceral leishmaniasis.

R. Borojevic, K. Luz, M. Palatnik, 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Prevalence of anti-Leishmania donovani antibody among Brazilian blood donors and multiply transfused hemodialysis patients.

F. C. Machado, K. Luz, V. D. da Silva, 1997, The American journal of tropical medicine and hygiene.

The FML (Fucose Mannose Ligand) of Leishmania donovani. a new tool in diagnosis, prognosis, transfusional control and vaccination against human kala-azar.

K. Luz, E. P. de Souza, W. R. dos Santos, 1996, Revista da Sociedade Brasileira de Medicina Tropical.

Transmission of visceral leishmaniasis by blood transfusion in hamsters.

R. Borojevic, K. Luz, C. B. Palatnik-de-Sousa, 1996, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

First report of interruption of mast cell degranulation and endothelial cells activation by anti-inflammatory drugs controlling the acute response provoked by Pseudoplatystoma fasciatum fish venom.

P. Charvet, M. Lopes-Ferreira, Carla Lima, 2014, Toxicon : official journal of the International Society on Toxinology.

Experimental murine Leishmania donovani infection: immunoprotection by the fucose-mannose ligand (FML).

R. Borojevic, C. B. Palatnik-de-Sousa, E. M. Gomes, 1994, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.